MONTRÉAL, Feb. 27, 2017 /CNW Telbec/ - The CHU Sainte-Justine and the CHU Sainte-Justine Foundation cordially invite you to celebrate the promising future of stem cell research to improve treatment and develop a cure for congenital heart defects thanks to an exceptional gift from Canadian Pacific.
The event will be an opportunity to recognize the major impact of such strong support for research at the CHU Sainte-Justine, as well as the national importance of research in the development of innovative new stem cell technologies.
A tour of Dr. Andelfinger's laboratory will be offered after the press conference.
Date: Monday, February 27, 2017
Time: From 11:00-11:30 am (tour of the laboratory at 11:30)
Place: CHU Sainte-Justine (Atrium)
(3175 Côte-Sainte-Catherine Road)
The following individuals will be present for the announcement:
- Mr. Keith Creel, President and CEO of Canadian Pacific
- The Honourable Michael M. Fortier, PC, Chairman of the Board of Directors, CHU Sainte-Justine Foundation
- Dr. Gregor Andelfinger, pediatric cardiologist at the CHU Sainte-Justine and associate research professor in the Department of Pediatrics, Université de Montréal
- Parents and children who live with the daily effects of cardiac illness.
SOURCE CHU Sainte-Justine Foundation
For further information: Delphine Brodeur, Director, Communication, Public Relations and Donor Relations, CHU Sainte-Justine Foundation, 514-345-4931, ext. 4356, firstname.lastname@example.org